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Abstract
Background: Nowadays, more and more novel enzymes can be easily found in the whole enzyme
pool with the rapid development of genetic operation. However, experimental work for substrate
screening of a new enzyme is laborious, time consuming and costly. On the other hand, many
computational methods have been widely used in lead screening of drug design. Seeing that the
ligand-target protein system in drug design and the substrate-enzyme system in enzyme applications
share the similar molecular recognition mechanism, we aim to fulfill the goal of substrate screening
by in silico means in the present study.
Results: A computer-aided substrate screening (CASS) system which was based on the enzyme
structure was designed and employed successfully to help screen substrates of Candida antarctica
lipase B (CALB). In this system, restricted molecular docking which was derived from the
mechanism of the enzyme was applied to predict the energetically favorable poses of substrate-
enzyme complexes. Thereafter, substrate conformation, distance between the oxygen atom of the
alcohol part of the ester (in some compounds, this oxygen atom was replaced by nitrogen atom of
the amine part of acid amine or sulfur atom of the thioester) and the hydrogen atom of imidazole
of His224, distance between the carbon atom of the carbonyl group of the compound and the
oxygen atom of hydroxyl group of Ser105 were used sequentially as the criteria to screen the
binding poses. 223 out of 233 compounds were identified correctly for the enzyme by this
screening system. Such high accuracy guaranteed the feasibility and reliability of the CASS system.
Conclusion:  The idea of computer-aided substrate screening is a creative combination of
computational skills and enzymology. Although the case studied in this paper is tentative, high
accuracy of the CASS system sheds light on the field of computer-aided substrate screening.
Background
Enzyme catalyzes a wide variety of chemical reactions
with great efficiency and specificity [1]. Applications of
enzymes in industrial catalysis continue to grow because
of their considerable advantages [2]. Although the classi-
cal approach of cultivating and characterizing isolates on
the strain level prior to gene isolation is valid and power-
ful, it is severely restricted in scope [3]. So capturing the
genes of organisms that have evolved as participants in
biotopes promises to revolutionize and broaden enzyme
applications in the chemical industry [2]. By the analysis
of relationships among sequence, structure and activity
[4], the function of newly obtained biocatalysts can be
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identified. However, broadening enzyme substrate specif-
icity [4] is still a tough task most of the time.
On the other hand, computer-aided drug design (CADD)
[5], especially different new protein inhibitors design [6-
9], has been developed rapidly. Many theories and meth-
odologies have been brought forward in this field [10-12].
More and more new drugs have been designed [13-16] by
in silico methods. In view of the similar molecular recog-
nition nature between ligand-target protein system and
enzyme-substrate system [17], molecular docking [17,18]
which was used in CADD to find the binding pattern
between ligand and target protein was applied to broaden
enzyme mapping of substrates in this study.
Although molecular docking is efficient in predicting
energetically favourable poses of ligand [19], it may be
inappropriate for explaining the substrate-enzyme reac-
tions sometimes. Because in some situations, substrates
may adopt energetically unfavourable poses which can
not be accounted by molecular docking to facilitate the
catalytic reactions that are mediated by enzymes [20]. It is
especially true when the catalysis step is the actual rate-
determining step. So we employed a third screening crite-
rion in our designed screening system to address the prob-
lem (see "Distance 2 Check" section of the Method).
Although the most accurate way of studying substrate-
enzyme reactions is the quantum chemical (QM) level
computation [21], its application in biomacromolecules
is too costly to be achieved at present. So molecular dock-
ing, a rough but much less costly computational tool, was
used to simulate the substrate binding step of the enzyme
reaction process. Although the structure-based CASS sys-
tem developed in the present study seemed simple and
coarse, its screening accuracy was unexpectedly high. 223
out of 233 tested compounds were identified correctly for
the enzyme by CASS. This suggests that biotechnologists
can use the same computational means to reduce their
mount of experimental work.
Results and Discussion
Measurements of all binding conformations for each
compound were listed in the Table S1 of Additional file 1.
Then lowest energy conformations (always the first con-
formation) were picked out for the checking system
(Table S2 of Additional file 1). As figure 1 showed, 19 out
of 233 compounds were rejected by "Conformational
Check". The rest 214 compounds were subject to the sec-
ond screening criterion – "Distance 1 Check". Only 78
compounds were accepted. Finally, the 136 rejected com-
pounds were screened by the third screening standard –
"Distance 2 Check". Through this step, another group of
112 compounds was accepted. Altogether, 190 of the 233
compounds were accepted as potential substrates of
CALB. The remnant 43 compounds were considered not
to be catalyzed by the enzyme.
Generally speaking, experimental work should be carried
out to inspect the accuracy of the in silico screening result.
However, all the 233 compounds used in the present
study had been fortunately reported by references (refer-
ences were listed in Additional file 1). By comparing the
virtual screening results with the reported experimental
observations, we found an unexpected but inspiring
result: all 190 compounds accepted by CASS system were
confirmed to be catalyzed by the enzyme; 33 out of the 43
rejected compounds were verified as inappropriate sub-
strate of the enzyme; in all, 223 out of the 233 tested com-
pounds were identified correctly by the in silico screening
system. Such high accuracy of the method (95.7%) guar-
anteed not only the feasibility but also the availability of
the CASS system.
There were still 10 compounds which were predicted mis-
takenly by the CASS system. The error would probably
come from molecular docking, because substrates may
adopt energetically unfavourable poses which can not be
accounted by molecular docking to facilitate the catalytic
reactions.
Conclusion
In the present study, the idea of computer-aided enzyme
substrate screening (CASS) was introduced, designed and
applied successfully to CALB. 223 out of 233 compounds
were identified correctly by this in silico screening system.
Such high accuracy of the method guaranteed both the
feasibility and the reliability of the CASS system. Although
the idea of structure-based computer-aided substrate
Screening result of the CASS Figure 1
Screening result of the CASS.BMC Bioinformatics 2009, 10:257 http://www.biomedcentral.com/1471-2105/10/257
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screening sounds wonderful, its application seems more
difficult than lead screening in CADD because of three
main operational difficulties: (1) how to determine the 3-
D structure of enzyme; (2) how to define the screening cri-
teria to ensure availability and accuracy; (3) how to apply
the screening criteria to computer software. In this light,
there is still a long way to go. However, conformational
and geometrical checks which were used in this study sug-
gest clues. Our further work will revolve around the appli-
cation of the CASS system to a lipase which was
discovered by our own group recently [22]. We hope to
broaden the substrate mapping of it with less experimen-
tal work, meanwhile we would also check again the
method designed in this study.
Methods
Design of the computer-aided substrate screening system
As figure 2 showed, tested compounds were docked into
the binding site of enzyme by Affinity (InsightII, version
2000 release, Accelerys) which created at most four possi-
ble conformations between compound and enzyme. And
three parameters (compound conformations, and two
separate geometric distances) were measured. Then the
conformation with the lowest energy was picked out and
screened sequentially by three criteria: (1) "Conforma-
tional Check"; (2) "Distance 1 Check"; (3) "Distance 2
Check". All the three screening criteria, together with
other details of the CASS system, would be described in
the next few paragraphs in an order of what were shown
in figure 2.
Building the structures of the tested compounds
All 233 compounds which were used as tested com-
pounds were built by Builder (InsightII, version 2000
release, Accelerys), and energy minimised by Discover
(InsightII, version 2000 release, Accelerys) using the CVFF
force field. Their coordinates were stored in Additional
file 2.
Structure of enzyme and binding site
CALB was studied in the present study because it had been
widely used in the academic world as well as in industry
as an efficient biocatalyst for asymmetric transformation
of sec-alcohols and related compounds [23] due to its
high activity, stability and selectivity in both aqueous and
organic solutions [24].
So far there were six crystal structures of CALB in PDB
databank. And the ligand free enzyme (PDB code
1TCA[25]) was used as the starting point in this study. The
two N-acetyl-D-glucosamine (NAG) moieties in the struc-
ture were removed. Hydrogen atoms were added to the
enzyme and water molecules. The catalytic histidine, His
224, was defined as protonated. Then an iterative series of
energy minimizations were performed on the water
hydrogen, enzyme hydrogen, and full water molecules.
Finally, the whole system was energy minimized.
The transition state analog crystal structure of CALB (PDB
code 1LBS[26]) was used to help determine the binding
site. Residues within 12 Å of the phosphorous atom of the
N-hexylphosphonate ethyl ester (HEE) were selected (fig-
ure 3) and directly copied to the ligand free structure
(1TCA) as the binding site. This seemed not well justified
because ligand bound crystal structures were always used
preferably for docking study in most situations. However,
the reason why we copied the binding site determined by
1LBS to the ligand free structure (1TCA) was because
1TCA outperformed 1LBS in the self-docking experiment
of the present study. When we docked HEE back in to
1TCA and 1LBS using the same binding site, respectively,
RMSD between the docked ligand and the ligand found in
crystal structure were 1.35 Å and 1.54 Å for 1TCA and
1LBS (see Additional file 3). This suggested that 1TCA
could reproduce the experimentally determined ligand
conformation better than 1LBS could to. Besides, energy
of the binding pose of 1TCA was much lower (see Addi-
tional file 3). This indicated that using 1TCA as the target
structure for docking would probably produce more sta-
ble binding pose. Finally, all atoms RMSD between free
enzyme structure (1TCA) and the transition state analog
crystal structure (1LBS) was only 0.4 Å. This ensured that
binding site determined from 1LBS could be copied to
1TCA with little deviation.
Docking engine – Affinity
A great deal of docking programs using different searching
algorithms and scoring functions had been developed and
put into practice [27-30]. In this study, an energy-driven
docking method-Affinity (InsightII, version 2000 release,
Flow chart of the CASS Figure 2
Flow chart of the CASS.BMC Bioinformatics 2009, 10:257 http://www.biomedcentral.com/1471-2105/10/257
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Accelerys) was used because it offered a very flexible and
powerful docking protocol that comprised elements from
Monte Carlo. Besides, Affinity adopted a full molecular
mechanics force field in searching for and evaluating
docked structures with both the flexibility of binding site
and substrate. Figure 4 described its docking procedure.
First the compounds were docked manually into the bind-
ing site of CALB, thus resulting in a roughly docked com-
plex. Then it was energy minimized to obtain the starting
structure. After that, it moved the ligand by random com-
bination of translation, rotation, and torsional changes.
The random move of ligand sampled both the orienta-
tional and conformational spaces of the ligand with
respect to the receptor. It had the advantage that it could
get over any energy barrier on the potential energy surface.
However, randomly placing the ligand in the binding
pocket in some cases could potentially lead to very severe
divergences in the coulombic and vdW energies. So the
scale factor for the coulombic term and vdW term is scaled
down to 10-7. Then Affinity subsequently checked the
energy of the resulting randomly moved structure. If it was
within the energy tolerance parameter (1000 kcal/mol) of
the previous minimized structure, it was considered to
have passed the first step and the structure was then sub-
jected to energy minimization, the second step for fine-
tuning the docking. The final minimized structure was
accepted or rejected based on the energy criterion and its
similarity to structures found before. To prevent the search
from being trapped in a local, deep potential energy well,
two additional controls were adopted. Specifically, if the
second energy check failed too many times (set to 4) con-
secutively, it suggested that the last accepted structure may
be very low in energy and that it was difficult to generate
new structures based on it. Thus, the current minimized
structure, though it was not acceptable in energy, was used
in generating new structures. Another exception was that
if the search fails too many times (set to10) consecutively
in finding the next acceptable structure, the program con-
tinued the search based on the current structure although
it was very similar to one of the structures found previ-
ously (RMS distance being less than 0.5 Å). If the search
still could not find an acceptable structure after 60 trials,
the search aborted.
Mechanism based restricted docking
CALB followed the same reaction mechanism as serine
hydrolase [21] and an oxyanion hole was required to sta-
bilize the negative charge of the transition states and the
acyl-enzyme intermediate during a typical reaction [31].
Essential hydrogen bonds which were involved in oxy-
anion hole (figure 5) were kept fixed during docking. Such
hydrogen bonds fixed docking process was named
"restricted docking".
Conformational Check
X-ray diffraction of CALB indicated that its active site was
made up of two pockets. One of them was for acyl part of
the ester (acyl pocket) and the other for alcohol part (alco-
hol pocket) [26]. It seemed that the size of the acyl pocket
Binding site of CALB Figure 3
Binding site of CALB. The residues involved inbinding site 
include: 37–43, 46–48, 71–73, 76, and 79, 103–110, 131–142, 
144–145, 150–159, 161, 163–164, 183, 187–193, 201–202, 
223–229, 275–288. The transition state analogy – HEE in 
1LBS is presented in CPK type.
Procedures of restricted docking by Affinity Figure 4
Procedures of restricted docking by Affinity. Main pro-
tocol of Affinity is coloured cyan. But the yellow part shows 
that there are three hydrogen bonds constrained at 1.8 Å.BMC Bioinformatics 2009, 10:257 http://www.biomedcentral.com/1471-2105/10/257
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was larger than that of alcohol pocket [31]. So we pro-
posed a hypothetic conformational rule that the larger
part of the substrate might bind into the larger binding
pocket of the enzyme. And it may be used as the first
screening criterion in CASS if it was proved correct.
MD simulations of eight enzyme-substrate transition-
state complexes were carried out to inspect and verify the
accuracy of the conformational rule before it was used as
a screening criterion. The eight compounds (figure 6)
could be classified into three groups according to the
numbers of carbon atoms on each side of the ester bond
(or acid amine bond for compound H). If acyl part of the
compound contained more carbon atoms than the alco-
hol part (or amine part) did, it belonged to the "larger acyl
part and smaller alcohol (or amine) part" group (com-
pound A and H). If the alcohol part (or amine part) had
more carbon atoms, it belonged to the "larger alcohol (or
amine) part and smaller acyl part" group (compound B, C
and E). And if both sides had the equal numbers of carbon
atoms, it was called "equal size" group (compound D, F,
G). For each compound, two different initial binding con-
formations were built as the starting structures of MD sim-
ulation (figure 7). One conformation was that the larger
part of the substrate lay in the larger binding pocket (fig-
ure 7A), and the other was that the larger part of the sub-
strate lay in the smaller binding pocket (figure 7B). The
construction of each transition-state system and its fol-
lowing MD simulation was described in Additional file 4.
Result of the MD simulation proved the correctness of the
proposed conformational rule (see table s1 of Additional
file 4), so it was used as the first screening criteria of the
CASS system and named "Conformational Check".
Distance 1 Check
Once the substrate went into the binding site with correct
conformation, more detailed criteria were needed to filter
the substrate binding results. Two geometrically impor-
tant distances were adopted in CASS. One was distance 1
which referred to distance between the oxygen atom of the
alcohol part of the ester (if the substrate was an amine or
thiol ester, the oxygen atom was replaced by nitrogen and
sulfur atom) and the hydrogen atom of imidazole of
His224 (figure 5). Distance 1 was considered as an impor-
tant parameter to discriminate the enatioselectivity of sec-
ondary alcohols [32]. A shorter distance may suggest
greater affinity between enzyme and substrate. So com-
pounds which passed the "Distance 1 Check" were identi-
fied directly as the substrates of the enzyme without any
further check. Compounds which failed the "Distance 1
Check" would be further checked by "Distance 2 Check".
Affinity was an energy-driven docking engine. During the
docking process in this study, values of vdW potential
energy were always much larger than the values of electro-
static potential energy. So the values of atom vdW radius
[33,34] were used to determine the standard value of Dis-
tance 1. Distance 1 referred to distance between H atom
and O (or N, S) atom in all the tested compounds. So 2.78
Å, the sum of 1.58 Å (the average vdW radius of the O, N,
S) and 1.2 Å (the vdW radius of H), was used as the stand-
ard value of "Distance 1 Check".
Side-view of the active site of CALB in complex with esters Figure 5
Side-view of the active site of CALB in complex with 
esters. Red dashed bonds represent the three hydrogen 
bonds that are kept fixed during molecular docking. And 
their corresponding atoms are painted bold. The hollow 
arrow heads show the Distance 1 and Distance 2 which are 
used in "Distance 1 Check" and "Distance 2 Check" of the 
CASS.
Eight compounds for MD simulation Figure 6
Eight compounds for MD simulation.BMC Bioinformatics 2009, 10:257 http://www.biomedcentral.com/1471-2105/10/257
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Distance 2 Check
In some cases, Affinity may find no energy favorably bind-
ing conformations and would just give the energy unfavo-
rably binding conformations. This was allowable in our
substrate screening system. Because some compounds
would take the energy unfavorable binding patterns to
facilitate the reaction of compounds with biocatalyst. To
address the problem, "Distance 2 Check" was adopted. It
referred to distance between the carbon atom of the carb-
onyl group of the candidate compound and the oxygen
atom of hydroxyl group of Ser105 (figure 5). And it was a
subsidiary screening criterion of" Distance 1 Check" to
guarantee the sensitivity and availability of the in silico
system. A shorter distance was believed to better facilitate
the nucleophilic attack of Ser105 to the carbonyl group of
compounds. Only compounds which failed the "Distance
1 Check" could be further subjected to the "Distance 2
Check". 3.12 Å (sum of the atom vdW radius of C and O)
was used as the standard value, because "Distance 2
Check" contains C and O atom in all compounds.
List of abbreviations
CALB:  Candida antarctica lipase B; CADD: Computer-
aided drug design; CASS: Computer-aided substrate
screening; QM: Quantum chemical; MD: Molecular
dynamics; vdW: Van der Waals; HEE: N-hexylphospho-
nate ethyl ester; RMSD: Root mean square deviation.
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Additional material
Additional file 1
Screening results. Table S1 displays the all binding conformations of each 
compound. Table S2 shows the screening result of CASS system. Besides, 
all the references about tested compounds are listed.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-257-S1.doc]
Additional file 2
3D structures of all compounds used for substrate screening. All struc-
tures are stored in ".car" format (Insight-II readable).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-257-S2.rar]
Additional file 3
Docking N-hexylphosphonate ethyl ester (HEE) in 1TCA and 1LBS. 
This part compares the results of the self-docking experiment using 1TCA 
and 1LBS as the target structure in detail.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-257-S3.doc]
Different initial binding conformation of transition state of the CALB-D-phenylglycinemethylester complex Figure 7
Different initial binding conformation of transition state of the CALB-D-phenylglycinemethylester complex. D-
phenylglycinemethylester is covalently bound to Ser105. The two binding pockets are circled by dashed lines. (A) Initial binding 
conformation in which the larger part of the substrate binds into the larger pocket; (B) Initial binding conformation in which 
the larger part of the substrate binds into the smaller pocket.BMC Bioinformatics 2009, 10:257 http://www.biomedcentral.com/1471-2105/10/257
Page 7 of 7
(page number not for citation purposes)
Acknowledgements
The research is founded by National Basic Research Program of China (973 
Program) 2009CB724703.
References
1. Yingkai Z, Haiyan L, Weitao Y: Free energy calculation on
enzyme reactions with an efficient iterativeprocedure to
determine minimum energy paths on a combined ab initio
QM/MM potential energy surface.  J Chem Phys 2002,
112:3483-3491.
2. Robertson DE, Steer BA: Recent progress in biocatalyst discov-
ery and optimization.  Curr Opin Che Biol 2004, 8:141-149.
3. Lorenz P, Schleper C: Metagenome: a challenging source of
enzyme discovery.  J Mol Catal B: Enzym 2002, 19–20:13-19.
4. Jestin JL, Vichier GS: How to broaden enzyme substrate specif-
icity: strategies, implications and applications.  Res Microbiol
2005, 156:961-966.
5. Marshall GR: Computer-Aided Drug Design.  Ann Rev Pharmacol
Toxical 1987, 27:193-213.
6. Lecaille F, Kaleta J, Brömme D: Human and parasitic papain-like
cysteine proteases: their role in physiology and pathology
and recent developments in inhibitor design.  Chem Rev 2002,
102:4459-4488.
7. Ring CS, Sun E, McKerrow JH, Lee GK, Rosenthal PJ, Kuntz ID, Cohen
FE: Structure-based inhibitor design by using protein models
for the development of antiparasitic agents.  Proc Natl Acad Sci
USA 1993, 90:3583-3587.
8. Lin TW, Melgar MM, Kurth D, Swamidass SJ, Purdon J, Tseng T, Gago
G, Baldi P, Gramajo H, Tsai SC: Structure-based inhibitor design
of AccD5, an essential acyl-CoA carboxylase carboxyltrans-
ferase domain of Mycobacterium tuberculosis.  Proc Natl Acad
Sci USA 2006, 103:3072-3077.
9. Kumaran D, Rawat R, Ludivico ML, Ahmed SA, Swaminathan S:
Structure and substrate based inhibitor design for clostrid-
ium botulinum neurotoxin serotype A.  J Biol Chem 2008,
283:18883-18891.
10. Taft CA, Da Silva VB, Da Silva CH: Current topics in computer-
aided drug design.  J Pharm Sci 2008, 97:1089-1098.
11. Veselovsky AV, Ivanov AS: Strategy of computer-aided drug
design.  Curr Drug Targets Infect Disord 2003, 3:33-40.
12. Jackson RC: Update on computer-aided drug design.  Curr Opin
Biotechnol 1995, 6:646-651.
13. Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF,
Man CF, Baragi V, Kilgore K, Dyer RD, Han HK: Quinazolinones
and pyrido [3,4-d] pyrimidin-4-ones as orally active and spe-
cific matrix metalloproteinase-13 inhibitors for the treat-
ment of osteoarthritis.  J Med Chem 2008, 51:835-841.
14. Park H, Jeon YH: Toward the virtual screening of Cdc25A
phosphatase inhibitors with the homology modeled protein
structure.  J Mol Model 2008, 14(9):833-841.
15. Cogan DA, Aungst R, Breinlinger EC, Fadra T, Goldberg DR, Hao
MH, Kroe R, Moss N, Pargellis C, Qian KC, Swinamer AD: Struc-
ture-based design and subsequent optimization of 2-tolyl-
(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP
kinase.  Bioorg Med Chem Lett 2008, 18:3251-3255.
16. Chen X, Zhong S, Zhu X, Dziegielewska B, Ellenberger T, Wilson GM,
MacKerell AD, Tomkinson AE: Rational design of human DNA
ligase inhibitors that target cellular DNA replication and
repair.  Cancer Res 2008, 68:3169-3177.
17. Mohan V, Gibbs AC, Cummings MD, Jaeger EP, DesJarlais RL: Dock-
ing: successes and challenges.  Curr Pharm Des 2005, 11:323-333.
18. Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert
MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID,
Woolven JM, Peishoff CE, Head MS: A critical assessment of
docking programs and scoring functions.  J Med Chem 2006,
49:5912-5931.
19. Kroemer RT: Structure-based drug design: docking and scor-
ing.  Curr Protein Pept Sci 2007, 8(4):312-328.
20. Mulholland AJ: Modelling enzyme reaction mechanisms, spe-
cificity and catalysis.  Drug Discov Today 2005, 10(20):1393-1402.
21. Hu CH, Brinck T, Hult K: Ab Initio and Density Functional The-
ory Studies of the Catalytical Mechanism for Ester Hydroly-
sis in Serine Hydrolase.  International journal of quantum chemistry
1998, 69:89-103.
22. Gao B, Su EZ, Lin JP, Jiang ZB, Ma YS, Wei DZ: Development of
recombinant Escherichia coli whole-cell biocatalyst express-
ing a novel alkaline lipase-coding gene from Proteus sp. for
biodiesel production.  J Biotech 139(2):169-175.
23. Rotticci D, Rotticci-Mulder JC, Denman S, Norin T, Hult K:
Improved enantioselectivity of a lipase by rational protein
engineering.  Chembiochem 2001, 2:766-770.
24. Magnusson AO, Rotticci-Mulder JC, Santagostino A, Hult K: Creat-
ing space for large secondary alcohols by rational redesign of
Candida antarctica lipase B.  Chembiochem 2001, 6:1051-1056.
25. Uppenberg J, Hansen MT, Patkar S, Jones TA: The sequence, crys-
tal structure determination and refinement of two crystal
formsof lipase B from Candida antarctica.  Structure 1994,
2:293-308.
26. Uppenberg J, Ohrner N, Norin M, Hult K, Kleywegt GJ, Patkar S,
Waagen V, Anthonsen T, Jones TA: Crystallographic and molec-
ular-modeling studies of lipase B from Candida antarctica
reveal a stereospecificity pocket for secondary alcohols.  Bio-
chemistry 1995, 34:16838-16851.
27. Halperin I, Ma B, Wolfson H, Nussinov R: Principles of docking:
An overview of search algorithms and a guide to scoring
functions.  Proteins 2002, 47:409-443.
28. Kitchen DB, Decornez H, Furr JR, Bajorath J: Docking and scoring
in virtual screening for drug discovery: methods and applica-
tions.  Nat Rev Drug Discov 2004, 3:935-949.
29. Kellenberger E, Rodrigo J, Muller P, Rognan D: Comparative eval-
uation of eight docking tools for docking and virtual screen-
ing accuracy.  Proteins 2004, 57:225-242.
3 0 . B u r s u l a y a  B D ,  T o t r o v  M ,  A b a g y a n  R ,  B r o o k s  C L :  Comparative
study of several algorithms for flexible ligand docking.  J Com-
put Aided Mol Des 2003, 17:755-763.
31. Gotor Fernandez V, Busto E, Gotor V: Candida antarctica lipase
B: An ideal biocatalyst for the preparation of nitrogenated
organic compounds.  Advanced synthesis & catalysis 2006,
348:797-812.
32. Schulz T, Pleiss J, Schmid RD: Stereoselectivity of Pseudomonas
cepacia  lipase toward secondary alcohols: a quantitative
model.  Protein Sci 2000, 9:1053-1062.
33. Bodi A: van der Waals Volumes and Radii.  J Phys Chem 1964,
68:441-442.
34. Rowland RS, Taylor R: Intermolecular Nonbonded Contact
Distances in Organic Crystal Structures: Comparison with
Distances Expected from van der Waals Radii.  J Phys Chem
1967, 100:7384-7391.
Additional file 4
MD simulation of the transition state of CALB-substrate complex. This 
part displays a detailed description of the preparation of transition state of 
enzyme-substrate complex and the following MD simulation results. Table 
S1 shows the result of MD simulation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-10-257-S4.doc]